Upcoming events – United seeks a Distinct hit, and Biogen nears a rare catalyst

Upcoming events – United seeks a Distinct hit, and Biogen nears a rare catalyst

Source: 
EP Vantage
snippet: 

A low-key lung cancer readout approaches for United Therapeutics’ Unituxin, while Biogen hopes to buck the tau trend.